Literature DB >> 31701290

Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.

Xianghai Ren1,2, Haibo Li1,2, Mei Diao2, Hang Xu1,2, Long Li3,4.   

Abstract

BACKGROUND: Impact of R1 (microscopically margin-positive) resection on survival of patients with hepatoblastoma (HB) remains debatable. This study aimed to compare the long-term outcomes of R0 (microscopically margin-negative) and R1 resection for HB in children after hepatectomy.
METHODS: We retrospectively reviewed files of children with HB who underwent resection at our institution between September 1, 2005, and November 30, 2017. Survival analyses and prognostic factors were evaluated using Kaplan-Meier curves and Cox regression models.
RESULTS: Of 259 patients, 218 (84.2%) underwent R0 and 41 (15.8%) R1 resection. After adjusting for confounding factors, R1 resection demonstrated non-significantly lower overall survival (OS: hazard ratio [HR] = 0.75; 95% CI 0.34-1.64) and shorter event-free survival (EFS: HR = 0.97; 95% CI 0.53-1.78) rates than R0 resection. However, stratified analysis showed significantly increased risk of poor OS and EFS in patients with metastasis and mixed epithelial/mesenchymal pathologic subtype in R1 compared with R0 resection (P values for interactions < 0.05). There was no significant difference between R0 resection with metastasis and R1 resection with metastasis in the incidence of local recurrence (P = 0.494); however, a significant difference in the incidence of local recurrence was seen between R0 and R1 resection for subgroups with mixed pathologic subtypes (P = 0.035).
CONCLUSIONS: With effective chemotherapy, microscopic margin status may not be associated with survival outcome in children with HB undergoing hepatectomy. However, stratified analysis showed that R1 resection might be associated with decreased survival in children with mixed epithelial/mesenchymal HB, compared with R0 resection, and not affect survival outcomes in those with an epithelial subtype and without metastasis.

Entities:  

Keywords:  Hepatectomy; Hepatoblastoma; Metastasis; Positive surgical margins; Survival rate

Year:  2019        PMID: 31701290     DOI: 10.1007/s10147-019-01573-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  30 in total

1.  Multifocal hepatoblastoma: What is the risk of recurrent disease in the remnant liver?

Authors:  Aodhnait S Fahy; Furqan Shaikh; Justin T Gerstle
Journal:  J Pediatr Surg       Date:  2019-02-02       Impact factor: 2.545

2.  Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.

Authors:  Rebecka L Meyers; Rudolf Maibach; Eiso Hiyama; Beate Häberle; Mark Krailo; Arun Rangaswami; Daniel C Aronson; Marcio H Malogolowkin; Giorgio Perilongo; Dietrich von Schweinitz; Marc Ansari; Dolores Lopez-Terrada; Yukichi Tanaka; Rita Alaggio; Ivo Leuschner; Tomoro Hishiki; Irene Schmid; Kenichiro Watanabe; Kenichi Yoshimura; Yurong Feng; Eugenia Rinaldi; Davide Saraceno; Marisa Derosa; Piotr Czauderna
Journal:  Lancet Oncol       Date:  2016-11-22       Impact factor: 41.316

3.  Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma.

Authors:  Timothy B Lautz; Tamar Ben-Ami; Niramol Tantemsapya; Yasmin Gosiengfiao; Riccardo A Superina
Journal:  Cancer       Date:  2010-11-16       Impact factor: 6.860

Review 4.  Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation.

Authors:  Rebecka L Meyers; Greg Tiao; Jean de Ville de Goyet; Riccardo Superina; Daniel C Aronson
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

5.  Surgical strategies for unresectable hepatoblastomas.

Authors:  Tatsuro Tajiri; Osamu Kimura; Shigehisa Fumino; Taizo Furukawa; Tomoko Iehara; Ryota Souzaki; Yoshiaki Kinoshita; Yuhki Koga; Aiko Suminoe; Toshiro Hara; Kenichi Kohashi; Yoshinao Oda; Tomoro Hishiki; Hajime Hosoi; Eiso Hiyama; Tomoaki Taguchi
Journal:  J Pediatr Surg       Date:  2012-12       Impact factor: 2.545

6.  Multidisciplinary effort in treating children with hepatoblastoma in China.

Authors:  Xiao-Jun Yuan; Huan-Min Wang; Hui Jiang; Meng-Jie Tang; Zhang-Lin Li; Xiang Zou; Yong-Jun Fang; Ci Pan; Jin-Fa Tou; Ke-Ren Zhang; Xiang Liu; Wei-Song Li; Yang Li; Jun Lu; Ye-Ming Wu
Journal:  Cancer Lett       Date:  2016-03-02       Impact factor: 8.679

7.  R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Authors:  Robbert J de Haas; Dennis A Wicherts; Eduardo Flores; Daniel Azoulay; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

Review 8.  Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies.

Authors:  Beate Haeberle; Dietrich von Schweinitz
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

9.  Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.

Authors:  József Zsiros; Laurence Brugieres; Penelope Brock; Derek Roebuck; Rudolf Maibach; Arthur Zimmermann; Margaret Childs; Daniele Pariente; Veronique Laithier; Jean-Bernard Otte; Sophie Branchereau; Daniel Aronson; Arun Rangaswami; Milind Ronghe; Michela Casanova; Michael Sullivan; Bruce Morland; Piotr Czauderna; Giorgio Perilongo
Journal:  Lancet Oncol       Date:  2013-07-04       Impact factor: 41.316

Review 10.  2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group.

Authors:  Derek J Roebuck; Daniel Aronson; Philippe Clapuyt; Piotr Czauderna; Jean de Ville de Goyet; Frédéric Gauthier; Gordon Mackinlay; Rudolf Maibach; Kieran McHugh; Oystein E Olsen; Jean-Bernard Otte; Danièle Pariente; Jack Plaschkes; Margaret Childs; Giorgio Perilongo
Journal:  Pediatr Radiol       Date:  2006-12-21
View more
  3 in total

Review 1.  A narrative review of the challenges and countermeasures in hepatoblastoma management during COVID-19 epidemic.

Authors:  Hang Xu; Yan Zhou; Rui Sun; Xuelai Liu; Mei Diao; Xianghai Ren; Long Li
Journal:  Transl Pediatr       Date:  2020-12

2.  Factors influencing recurrence after complete remission in children with hepatoblastoma: A 14-year retrospective study in China.

Authors:  Fan Li; Weiling Zhang; Huimin Hu; Xia Zhu; Yi Zhang; Dongsheng Huang
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

Review 3.  The challenges in colorectal cancer management during COVID-19 epidemic.

Authors:  Xianghai Ren; Baoxiang Chen; Yuntian Hong; Weicheng Liu; Qi Jiang; Jingying Yang; Qun Qian; Congqing Jiang
Journal:  Ann Transl Med       Date:  2020-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.